Company · founded 1969

Leidos (United States)

Reston, United States · leidos.com

Manage this page

Citations, last 5 years: 6 675
Works, last 5 years: 1 109
h-index: 290
Scientists listed: 163
Grants since 2016: 653

Grants received

2011–2021 · contract · N01

Task X11: Anti-Ricin Monoclonal Antibody Product Development

Casey Koontz · Leidos (United States) · funded by National Institutes of Health

$52.2k

2011–2021 · contract · N01

TASK X13: MANUFACTURE OF ANTI-POLIOVIRUS ANTIBODIES

Casey Koontz · Leidos (United States) · funded by National Institutes of Health

$27.6k

2011–2021 · contract · N01

Task X18: Development of Biopharmaceutical Products Program

Casey Koontz · Leidos (United States) · funded by National Institutes of Health

$204.3k

2011–2021 · contract · N01

TASK 16: Production of Botulinum Complex

Casey Koontz · Leidos (United States) · funded by National Institutes of Health

$37.4k

2011–2021 · contract · N01

TASK 17: Manufacture of mAb Clinical Material

Casey Koontz · Leidos (United States) · funded by National Institutes of Health

$2.5M

2011–2021 · contract · N01

Task 7: The Biopharmaceutical Product Development Services Program

Jon Carl Mirsalis · Leidos (United States) · funded by National Institutes of Health

$272.5k

2011–2021 · contract · N01

TASK 16: Production of Botulinum Complex

Casey Koontz · Leidos (United States) · funded by National Institutes of Health

$198.7k

2011–2021 · contract · N01

Task 9: Biopharmaceutical Product Development Services program

Jon Carl Mirsalis · Leidos (United States) · funded by National Institutes of Health

$987.3k

2011–2021 · contract · N01

Task 9: Product Validation - Biopharmaceutical Product Development Services program

Casey Koontz · Leidos (United States) · funded by National Institutes of Health

$100.4k

2011–2021 · contract · N01

Biopharmaceutical Product Development Services Program

Jon Carl Mirsalis · Leidos (United States) · funded by National Institutes of Health

$217.2k

2011–2021 · contract · N01

Task 7: The Biopharmaceutical Product Development Services Program

Jon Carl Mirsalis · Leidos (United States) · funded by National Institutes of Health

$54.2k

2011–2021 · contract · N01

Task X19: UNIVERSAL INFLUENZA IGY ANTIBODIES FOR THERAPEUTIC APPLICATIONS

Casey Koontz · Leidos (United States) · funded by National Institutes of Health

$36.6k

2011–2021 · contract · N01

Task X14: Monoclonal Antibody for HCV

Casey Koontz · Leidos (United States) · funded by National Institutes of Health

$394.1k